Viewing Study NCT06207734


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-28 @ 11:45 PM
Study NCT ID: NCT06207734
Status: RECRUITING
Last Update Posted: 2025-05-01
First Post: 2024-01-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module